Inventor · disambiguated record
Kevin Hall Mcallister
Also filed as: MCALLISTER KEVIN HALL
6 granted patents·4 pending applications·1 citations·filing 2004–2022
69Inventor score
Top patents by PatentIndex Score
10 records- 0173US12215387B2Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 0267US9828642B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2015·Granted Nov 28, 2017·1 cites·11 claims
- 0366US2022211679A1Alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0462US11359241B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·8 claims
- 0561US11311525B2Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2017·Granted Apr 26, 2022·0 cites·9 claims
- 0650US2015313884A1Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 0749US2011212980A1Combinations for the treatment of migraineNOVARTIS AG·Filed 2009·Application pending·0 cites
- 0849US2010063029A1Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disordersBILBE GRAEME·Filed 2009·Application pending·0 cites
- 0947US7776851B2Use of neurokinin antagonists in the treatment of urinary incontinenceNOVARTIS AG·Filed 2004·Granted Aug 17, 2010·0 cites·2 claims
- 1046US7638510B2Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disordersNOVARTIS AG·Filed 2004·Granted Dec 29, 2009·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Hall Mcallister files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →